Controlled Substance Agreement Template – US

Disclaimer

The information provided is intended solely as a general example related to regulations governing the handling and prescribing of controlled substances. It does not constitute legal or medical advice and should not replace consultation with qualified professionals in healthcare or legal fields. Laws and regulations vary by jurisdiction, and adjustments may be necessary to ensure compliance with local requirements. The use of this example is at the user’s own risk, and no liability is assumed for any errors, omissions, or consequences arising from its use without proper professional guidance.

Please note: This is a sample Controlled Substance Agreement template for the United States, intended for reference purposes only. Actual terms may differ based on specific regulations and agreements.

Controlled Substance Agreement US – Sample Template

Parties Involved:

Dispenser: ABC Pharmacy LLC
Address: 123 Healthcare Blvd, Springfield, IL 62704

Patient: John Doe
Address: 456 Maple Street, Springfield, IL 62704

Controlled Substance Description:

The substances covered under this agreement include opioids, benzodiazepines, stimulants, and other controlled substances as specified in Schedule II-V of the Controlled Substances Act, to be dispensed in accordance with federal and state laws.

Terms and Conditions:

The patient agrees to use the prescribed controlled substances solely for lawful medical purposes, in accordance with the instructions provided by the healthcare provider, and to not divert or misuse the medication.

Dispenser Responsibilities:

The dispenser shall accurately record each prescription, provide counseling on proper use, storage, and disposal, and report any suspicious activity violating federal or state regulations.

Legal Compliance:

Both parties agree to adhere to applicable federal and state laws related to controlled substances, including the Drug Enforcement Administration (DEA) regulations and state pharmacy statutes.

Additional Provisions:

• The patient agrees to attend regular follow-up appointments and comply with monitoring requirements.
• This agreement may be modified only in writing authorized by both parties.
• Failure to comply with this agreement may result in discontinuation of controlled substance prescriptions.

Springfield, ______________________